Ryan Tarry

Ryan Tarry has extensive experience in the pharmaceutical industry. Starting in 2001 at ADP as a Sales Representative, they exceeded sales targets and conducted numerous presentations and cold calls. From 2002 to 2006, they worked at Forest Laboratories as a Specialty Sales Representative, successfully launching and promoting Lexapro, Namenda, and Benicar.

In 2006, Ryan joined Biogen as an Executive Territory Business Manager, overseeing education, sales, and pull through of specialty drugs for Multiple Sclerosis. Ryan also held leadership roles within the company and developed a network of key opinion leaders and speaker advocates.

From 2018 to 2021, Ryan worked at Akcea Therapeutics as an Associate Director. Ryan served as a Thought Leader Liaison, enhancing relationships with thought leaders in the amyloidosis and familial chylomicronemia syndrome therapeutic areas. Ryan also managed and developed accounts and provided education on rare diseases and genetic testing.

Most recently, Ryan joined Horizon in 2021 as a Specialty Account Manager. In this role, they managed and developed accounts focusing on Neuromyelitis Optica Spectrum Disorders. Ryan oversaw education, sales, and pull through of Uplizna and worked with MS Centers and general neurologists.

In 2022, Ryan joined TG Therapeutics, Inc. as an Associate Director, Key Accounts.

Ryan Tarry completed their Bachelor of Science (BS) in Education at SUNY Brockport from 1996 to 1999. Ryan then pursued a Master of Science (MS) degree in Sport and Fitness Administration/Management at Florida State University from 1999 to 2000.